Template:Fibromyalgia criteria 2016: Difference between revisions

Revision as of 16:59, 6 April 2022

2016 Revised Fibromyalgia Diagnostic Criteria
Widespread Pain Index
Pain and tenderness during the past week	Left	Right
Jaw
Neck
Shoulder
Upper arm
Lower arm
Chest or breast
Abdomen
Upper back
Lower back
Hip or buttocks
Upper leg
Lower leg
Generalised Pain Regions
Do not count jaws, chest, or abdomen	Left	Right
Arms
Legs
Spine
Result Negative Score: 0/10
Seminars in Arthritis and Rheumatism 46 (2016) 319 - 329

@@ Line 54: / Line 54: @@
 |<html><input class="start-item" name="three" type="checkbox" id="q3-n" value="10" onclick="window.startScore(this);" /></html>
 |<html><input class="start-item" id="q3-y" name="three" type="checkbox" value="0" onclick="window.startScore(this);" /></html>
+|-
+! colspan="3"| Generalised Pain Regions
+|-
+| '''Do not count jaws, chest, or abdomen'''
+| '''Left'''
+| '''Right'''
+|-
+|Arms
+|<html><input class="start-item" name="one" type="checkbox" id="q1-n" value="10" onclick="window.startScore(this);" /></html>
+|<html><input class="start-item" id="q1-y" name="one" type="checkbox" value="0" onclick="window.startScore(this);" /></html>
+|-
+|Legs
+|<html><input class="start-item" name="one" type="checkbox" id="q1-n" value="10" onclick="window.startScore(this);" /></html>
+|<html><input class="start-item" id="q1-y" name="one" type="checkbox" value="0" onclick="window.startScore(this);" /></html>
+|-
+|Spine
+|colspan="2"|<html><div style="margin-left:2.5rem;"><input class="start-item" name="one" type="checkbox" id="q1-n" value="10" onclick="window.startScore(this);" /></div></html>
 |-
 ! colspan="3" |<div style="display:flex; flex-direction:row; justify-content:space-around;"><div>Result</div><div><span class="interpretation" style="color: green;">Negative</span></div><div><span class="score">Score: 0/10</span></div></div>
 |-
-|colspan="3"|<small>Validated in painful diabetic polyneuropathy. At the cut-off of 4, DN4 displayed sensitivity of 80%, specificity of 92%, positive predictive value (PPV) of 82%, negative predictive value (NPV) of 91%, and likelihood ratio for a positive result (LR(+) ) of 9.6. At the cut-off of 3, DN4-interview showed sensitivity and specificity of 84%, PPV of 71%, NPV of 92%, and LR(+) of 5.3.<ref>Spallone V, Morganti R, D'Amato C, Greco C, Cacciotti L, Marfia GA. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med. 2012 May;29(5):578-85. doi: 10.1111/j.1464-5491.2011.03500.x. [https://pubmed.ncbi.nlm.nih.gov/22023377/#:~:text=Aims%3A%20DN4%20(Douleur%20Neuropathique%20en,formally%20been%20validated%20in%20diabetes. PMID]</ref></small>
+|colspan="3"|<small>Seminars in Arthritis and Rheumatism 46 (2016) 319 - 329</small>
 |}
 <div style="display:none"><html><script type="text/javascript">